Zhujiang Hospital

This early study tests a nasal spray made from tiny particles (extracellular vesicles) from umbilical cord stem cells in 9 people who had an ischemic stroke. The main goal is to check safety and find the right dose. Participants must be 18-70, have a blocked artery in the front o…

This early-stage trial tests whether Racecadotril, a drug given via feeding tube, can reduce organ injury in people with sepsis. About 44 adults in intensive care will receive either the drug or a placebo, along with standard sepsis treatment. The main goal is to see if organ fun…

This early-stage study tests a new treatment using a patient's own immune cells, called CAR-T cells, that are specially designed to attack cancer. The study includes 60 adults aged 18-80 with newly diagnosed B-cell acute lymphoblastic leukemia or lymphoma who cannot handle strong…

This study looks at people with advanced mouth or throat cancer who had chemotherapy and immunotherapy before surgery. After surgery, they will either get radiation, an immunotherapy drug (PD-1 inhibitor), or just be watched. The goal is to see which approach helps them live long…

This study tests a drug called romiplostim N01 in 60 adults with solid tumors (like lung or breast cancer) who have low platelets from radiation-based treatments. The goal is to see if it safely raises platelet counts within two weeks. It is a phase 2 trial, not yet recruiting, a…

This study tests whether combining two types of brain stimulation (tDCS and rTMS) can improve motor function in people with locked-in syndrome, a condition where a person is awake but cannot move or speak. Researchers will enroll 72 adults aged 18-70 who have had the condition fo…

This study looks at how a substance called lactate changes the bacteria in your gut and how that might be linked to the worsening of liver cirrhosis. Researchers will compare 200 people with and without liver disease. No treatment is given—only observation and sample collection.…

This study looks at whether a specific gut bacterium, Ruminococcus gnavus, and the chemicals it produces are connected to metabolic dysfunction-associated fatty liver disease (MAFLD). Researchers will compare 200 healthy people and those with MAFLD to find patterns. The goal is t…